T. Ivanova

Cardiology and Cardiovascular Medicine · 2016

A researcher in the Science corpus: 1 paper; trusts 17 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 76 citations into it
• Surgery — 38 citations into it
• Endocrinology, Diabetes and Metabolism — 35 citations into it
• Public Health, Environmental and Occupational Health — 26 citations into it
• Physiology — 24 citations into it
• Nutrition and Dietetics — 12 citations into it
• Cancer Research — 9 citations into it
• Family Practice — 8 citations into it

Whom T. Ivanova trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. R. Shephard
2. M. Woodward
3. W. J. Howard
4. Vaughn Barry
5. F. He
6. L. Stead
7. P. P. Toth
8. N. Wong
9. P. Brindle
10. T. Lancaster

Who trusts T. Ivanova overall

1. T. Anderson
2. I. Graham

Papers from T. Ivanova's perspective

Ordered by how strongly the researchers T. Ivanova trusts endorse each paper. Same corpus, a different order for every researcher.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (The Lancet)
3. Medication Adherence: Its Importance in Cardiovascular Outcomes (Circulation)
4. Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies (Circulation)
5. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. (Archives of Internal Medicine)
6. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies (British medical journal)
7. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. (The Lancet)
8. Lipoprotein(a) as a cardiovascular risk factor: current status (European Heart Journal)
9. Home-based versus centre-based cardiac rehabilitation (Cochrane Database of Systematic Reviews)
10. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. (New England Journal of Medicine)

Their papers

• 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016) — 633 citations